Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care
出版年份 2022 全文链接
标题
Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care
作者
关键词
-
出版物
Journal of Personalized Medicine
Volume 12, Issue 3, Pages 454
出版商
MDPI AG
发表日期
2022-03-14
DOI
10.3390/jpm12030454
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and Efficacy of GLP-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis
- (2021) Paul M. Ryan et al. JOURNAL OF PEDIATRICS
- Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors
- (2021) Donna Shu-Han Lin et al. DIABETOLOGIA
- Treatment options following metformin in primary prevention populations with type 2 diabetes: which is the right road to take?
- (2021) Theocharis Koufakis et al. Expert Review of Clinical Pharmacology
- Safety of Semaglutide
- (2021) Mark M. Smits et al. Frontiers in Endocrinology
- Type 2 diabetic women are not small type 2 diabetic men: Sex-and-gender differences in antidiabetic drugs
- (2021) Ilaria Campesi et al. CURRENT OPINION IN PHARMACOLOGY
- Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus
- (2020) Valeria Raparelli et al. Journal of the American Heart Association
- Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
- (2020) Elvira D’Andrea et al. Cardiovascular Diabetology
- Gender differences in adverse event reports associated with antidiabetic drugs
- (2020) Kyung-In Joung et al. Scientific Reports
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- GLP‐1 agonists for obesity and type 2 diabetes in children: Systematic review and meta‐analysis
- (2020) Karan R. Chadda et al. Obesity Reviews
- Navigating the “MACE” in Cardiovascular Outcomes Trials and decoding the relevance of Atherosclerotic Cardiovascular Disease benefits versus Heart Failure benefits
- (2019) Christopher Hupfeld et al. DIABETES OBESITY & METABOLISM
- MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
- (2019) Michael A Nauck et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis
- (2019) Marco Castellana et al. Scientific Reports
- Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
- (2019) Maria Mirabelli et al. International Journal of Environmental Research and Public Health
- Exposure-response analysis for evaluation of semaglutide dose levels in type 2 diabetes
- (2018) Kristin C. C. Petri et al. DIABETES OBESITY & METABOLISM
- Gender differences in glucose homeostasis and diabetes
- (2018) Franck Mauvais-Jarvis PHYSIOLOGY & BEHAVIOR
- Sex differences underlying pancreatic islet biology and its dysfunction
- (2018) Maureen Gannon et al. Molecular Metabolism
- Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
- (2018) Eugene Han et al. Diabetes Therapy
- Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
- (2018) Eugene Han et al. Diabetes Therapy
- The Pathophysiology of Gestational Diabetes Mellitus
- (2018) Jasmine Plows et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
- (2016) Rune V. Overgaard et al. CLINICAL PHARMACOKINETICS
- Gastrointestinal safety across the albiglutide development programme
- (2016) L. A. Leiter et al. DIABETES OBESITY & METABOLISM
- Exposure-response analyses of liraglutide 3.0 mg for weight management
- (2016) J. P. H. Wilding et al. DIABETES OBESITY & METABOLISM
- Subgroup analysis of phase 3 studies of dulaglutide in Japanese patients with type 2 diabetes
- (2016) Yukiko Onishi et al. ENDOCRINE JOURNAL
- Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
- (2016) Alexandra Kautzky-Willer et al. ENDOCRINE REVIEWS
- Gender-related different effects of a combined therapy of Exenatide and Metformin on overweight or obesity patients with type 2 diabetes mellitus
- (2016) Huibiao Quan et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight
- (2016) Heike Vogel et al. NEUROPHARMACOLOGY
- Sex and estrogens alter the action of glucagon-like peptide-1 on reward
- (2016) Jennifer E. Richard et al. Biology of Sex Differences
- Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States
- (2016) Emily Durden et al. JOURNAL OF MEDICAL ECONOMICS
- Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials
- (2015) Jeanne S. Geiser et al. CLINICAL PHARMACOKINETICS
- Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis
- (2015) Feng Sun et al. CLINICAL THERAPEUTICS
- A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes
- (2015) Michael A. Nauck et al. DIABETES CARE
- Enumerating β-Cells in Whole Human Islets: Sex Differences and Associations With Clinical Outcomes After Islet Transplantation
- (2015) Enza Marchese et al. DIABETES CARE
- Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database
- (2015) M. Sue Kirkman et al. DIABETES CARE
- Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy
- (2015) Eusebio Chiefari et al. Diabetes Technology & Therapeutics
- Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects
- (2015) Reinhard H. A. Becker et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Menopause
- (2015) Traci A. Takahashi et al. MEDICAL CLINICS OF NORTH AMERICA
- Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients
- (2015) Shereen Aleidi et al. SAUDI PHARMACEUTICAL JOURNAL
- Liraglutide: A Review of Its Use in Adult Patients with Type 2 Diabetes Mellitus
- (2014) Lesley J. Scott DRUGS
- Effects of GLP-1 on appetite and weight
- (2014) Meera Shah et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro
- (2014) Robert Root-Bernstein et al. Frontiers in Endocrinology
- Sex differences in type 2 diabetes: focus on disease course and outcomes
- (2014) Lisa Arnetz et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Sex Differences in All-Cause and Cardiovascular Mortality, Hospitalization for Individuals With and Without Diabetes, and Patients With Diabetes Diagnosed Early and Late
- (2013) Madonna M. Roche et al. DIABETES CARE
- Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials
- (2013) B. Wang et al. DIABETES OBESITY & METABOLISM
- Effect of gender on treatment outcomes in type 2 diabetes mellitus
- (2013) J.B. McGill et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis
- (2013) Franck Mauvais-Jarvis et al. ENDOCRINE REVIEWS
- Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience
- (2013) Giuseppe Seghieri et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Targeted estrogen delivery reverses the metabolic syndrome
- (2012) Brian Finan et al. NATURE MEDICINE
- Exenatide Twice Daily: Analysis of Effectiveness and Safety Data Stratified by Age, Sex, Race, Duration of Diabetes, and Body Mass Index
- (2012) Richard Pencek et al. POSTGRADUATE MEDICINE
- Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability
- (2011) A. J. Garber DIABETES CARE
- One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice
- (2010) M. Buysschaert et al. DIABETES & METABOLISM
- Risk factors for cardiovascular disease in women with diabetes
- (2010) Christine Maric Gender Medicine
- Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity
- (2008) R Pasquali et al. INTERNATIONAL JOURNAL OF OBESITY
- Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes
- (2008) Jessica E. Matthews et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started